These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12442077)

  • 1. [Pathophysiology of cerebrospinal meningitis].
    Nassif X
    Ann Med Interne (Paris); 2002 Sep; 153(5):318-22. PubMed ID: 12442077
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular mechanisms involved in the interaction of Neisseria meningitidis with cells of the human blood-cerebrospinal fluid barrier.
    Schubert-Unkmeir A
    Pathog Dis; 2017 Mar; 75(2):. PubMed ID: 28334198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between encapsulated Neisseria meningitidis and host cells.
    Nassif X
    Int Microbiol; 1999 Sep; 2(3):133-6. PubMed ID: 10943405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral microcirculation shear stress levels determine Neisseria meningitidis attachment sites along the blood-brain barrier.
    Mairey E; Genovesio A; Donnadieu E; Bernard C; Jaubert F; Pinard E; Seylaz J; Olivo-Marin JC; Nassif X; Duménil G
    J Exp Med; 2006 Aug; 203(8):1939-50. PubMed ID: 16864659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD46 in meningococcal disease.
    Johansson L; Rytkonen A; Bergman P; Albiger B; Källström H; Hökfelt T; Agerberth B; Cattaneo R; Jonsson AB
    Science; 2003 Jul; 301(5631):373-5. PubMed ID: 12869763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living in a changing environment: insights into host adaptation in Neisseria meningitidis from comparative genomics.
    Schoen C; Joseph B; Claus H; Vogel U; Frosch M
    Int J Med Microbiol; 2007 Nov; 297(7-8):601-13. PubMed ID: 17572149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between Neisseria meningitidis and human cells that promote colonisation and disease.
    Corbett A; Exley R; Bourdoulous S; Tang CM
    Expert Rev Mol Med; 2004 Jul; 6(14):1-14. PubMed ID: 15245588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of meningococcal virulence factors with endothelial cells at the human blood-cerebrospinal fluid barrier and their role in pathogenicity.
    Simonis A; Schubert-Unkmeir A
    FEBS Lett; 2016 Nov; 590(21):3854-3867. PubMed ID: 27498906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcemia: epidemiology, pathophysiology, and management.
    Milonovich LM
    J Pediatr Health Care; 2007; 21(2):75-80. PubMed ID: 17321906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of meningococcal meningitis in Brazil by use of PCR.
    Pedro LG; Boente RF; Madureira DJ; Matos JA; Rebelo CM; Igreja RP; Barroso DE
    Scand J Infect Dis; 2007; 39(1):28-32. PubMed ID: 17366009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal meningitis and a negative cerebrospinal fluid: case report and its medicolegal implications.
    Huynh W; Lahoria R; Beran RG; Cordato D
    Emerg Med Australas; 2007 Dec; 19(6):553-5. PubMed ID: 18021109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diversification of Neisseria meningitidis during waves of colonization and disease in the meningitis belt of sub-Saharan Africa.
    Leimkugel J; Forgor AA; Dangy JP; Pflüger V; Gagneux S; Hodgson A; Pluschke G
    Vaccine; 2007 Sep; 25 Suppl 1():A18-23. PubMed ID: 17531357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke secondary to meningococcal meningitidis: a potential link between endothelial dysfunction and cytokines.
    de Souza AL; Seguro AC
    Arch Neurol; 2008 Feb; 65(2):283-4; author reply 284. PubMed ID: 18268204
    [No Abstract]   [Full Text] [Related]  

  • 14. Interactions and Signal Transduction Pathways Involved during Central Nervous System Entry by
    Borkowski J; Schroten H; Schwerk C
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage variation: understanding the behaviour of an accidental pathogen.
    Moxon ER; Jansen VA
    Trends Microbiol; 2005 Dec; 13(12):563-5. PubMed ID: 16257527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of Neisseria meningitidis meningitis in Togo during 2003-2005.
    Adjogble KL; Lourd M; Njanpop-Lafourcade BM; Traoré Y; Hlomaschi AF; Amegatse KA; Agbenoko K; Sanou O; Sita K; Mueller JE; Gessner BD
    Vaccine; 2007 Sep; 25 Suppl 1():A47-52. PubMed ID: 17517455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal meningitis by Neisseria meningitidis B.
    Tinsa F; Jallouli M; Ben Lassouad M; Smaoui H; Brini I; Bousseta K; Bousnina S
    Tunis Med; 2008 Nov; 86(11):1014-5. PubMed ID: 19213497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conquering the meningococcus.
    Stephens DS
    FEMS Microbiol Rev; 2007 Jan; 31(1):3-14. PubMed ID: 17233633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meningococcal meningitis without inflammatory reaction in the cerebrospinal fluid].
    Jover F; Andreu L; Cuadrado JM; Merino J
    Rev Neurol; 2001 Apr 16-30; 32(8):800. PubMed ID: 16245405
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid-glutamic oxalacetic transaminase activity in experimental meningitis.
    Belsey MA
    Antimicrob Agents Chemother (Bethesda); 1966; 6():19-23. PubMed ID: 5982339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.